Shannon Ferrante
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Liver Disease and Transplantation
- Infectious Diseases top 10%
- Viral gastroenteritis research and epidemiology
- HIV/AIDS drug development and treatment
Papers in
- Hepatology 18
- Hepatitis C virus research 16
- Epidemiology 13
- Liver Disease Diagnosis and Treatment 10
- Hepatitis B Virus Studies 7
- Co-authors
- Aino Karvonen (2 shared papers)Max Ciarlet (2 shared papers)Timo Vesikari (2 shared papers)Elamin H. Elbasha (10 shared papers)Jagpreet Chhatwal (10 shared papers)Antoine C. El Khoury (3 shared papers)Barbara J. Kuter (1 shared paper)Yogesh Punekar (2 shared papers)
- Journals
- Value in Health (8 papers)Blood (2 papers)Journal of Hepatology (2 papers)Advances in Therapy (2 papers)HIV Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Shannon Ferrante
35 papers receiving 454 citations
Peers
Comparison fields: 5 of 53
- Hepatology 255
- Infectious Diseases 208
- Virology 40
- Epidemiology 179
- Hematology 44
Countries citing papers authored by Shannon Ferrante
This map shows the geographic impact of Shannon Ferrante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon Ferrante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon Ferrante more than expected).
Fields of papers citing papers by Shannon Ferrante
This network shows the impact of papers produced by Shannon Ferrante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon Ferrante. The network helps show where Shannon Ferrante may publish in the future.
Co-authors
The 25 scholars most cited alongside Shannon Ferrante, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 69 | |
| 2 | 2010 | 65 | |
| 3 | 2013 | 56 | |
| 4 | 2013 | 42 | |
| 5 | 2021 | 33 | |
| 6 | 2013 | 28 | |
| 7 | 2022 | 20 | |
| 8 | 2019 | 19 | |
| 9 | 2012 | 18 | |
| 10 | 2019 | 16 | |
| 11 | 2012 | 14 | |
| 12 | 2014 | 12 | |
| 13 | 2015 | 8 | |
| 14 | 2021 | 7 | |
| 15 | 2022 | 7 | |
| 16 | 2022 | 5 | |
| 17 | 2011 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 2013 | 4 | |
| 20 | 2018 | 4 |
About Shannon Ferrante
Shannon Ferrante is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Hematology and Molecular Biology, having authored 36 papers that have together received 462 indexed citations. Recurring topics across this work include Hepatitis C virus research (16 papers), Liver Disease Diagnosis and Treatment (10 papers), HIV/AIDS drug development and treatment (9 papers), Multiple Myeloma Research and Treatments (9 papers), Hepatitis B Virus Studies (7 papers), Protein Degradation and Inhibitors (5 papers), Peptidase Inhibition and Analysis (3 papers) and HIV/AIDS Research and Interventions (2 papers). The work is most often cited by research in Hepatology (255 citations), Infectious Diseases (208 citations), Virology (40 citations), Epidemiology (179 citations) and Hematology (44 citations). Shannon Ferrante has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Aino Karvonen, Max Ciarlet, Timo Vesikari, Elamin H. Elbasha, Jagpreet Chhatwal, Antoine C. El Khoury, Barbara J. Kuter, Yogesh Punekar, Daniel Parks and Margaret Burroughs. Their work appears in journals such as Value in Health, Blood, Journal of Hepatology, Advances in Therapy and HIV Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.